Back
Pieris Pharmaceuticals Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
34
PIRS
Pieris Pharmaceuticals
Last Price:
16.00
Seasonality Move:
11.68%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
Pieris Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.39 | Sell |
| 20-day SMA: | 16.72 | Sell |
| 50-day SMA: | 16.66 | Sell |
| 200-day SMA: | 13.77 | Buy |
| 8-day EMA: | 16.32 | Sell |
| 20-day EMA: | 16.55 | Sell |
| 50-day EMA: | 16.38 | Sell |
| 200-day EMA: | 17.51 | Sell |
Pieris Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 39.38 | Sell |
| Chaikin Money Flow: | -79315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.3 - 17.04) | Sell |
| Bollinger Bands (100): | (11.57 - 18.63) | Buy |
Pieris Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pieris Pharmaceuticals Stock
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 15.95 while PIRS 8-day simple moving average is 16.39, which is a Sell signal.
- The stock price of PIRS is 15.95 while Pieris Pharmaceuticals 20-day SMA is 16.72, which makes it a Sell.
- Pieris Pharmaceuticals 50-day simple moving average is 16.66 while PIRS share price is 15.95, making it a Sell technically.
- PIRS stock price is 15.95 and Pieris Pharmaceuticals 200-day simple moving average is 13.77, creating a Buy signal.
PIRS Technical Analysis vs Fundamental Analysis
Sell
34
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy or a Sell?
-
Pieris Pharmaceuticals stock is rated a Sell
The current Pieris Pharmaceuticals [PIRS] share price is $15.95. The Score for PIRS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Pieris Pharmaceuticals Stock Info
Market Cap:
21.06M
Price in USD:
15.95
Share Volume:
96.58K
Pieris Pharmaceuticals 52-Week Range
52-Week High:
22.32
52-Week Low:
6.20
Sell
34
Pieris Pharmaceuticals (PIRS)
is a Sell
Pieris Pharmaceuticals Share Price Forecast
-
What is the Pieris Pharmaceuticals stock price today?
The Pieris Pharmaceuticals stock price is 15.95 USD today. -
Will PIRS stock go up or go down?
Pieris Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Pieris Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pieris Pharmaceuticals is overvalued.
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 15.95 while PIRS 8-day exponential moving average is 16.32, which is a Sell signal.
- The stock price of PIRS is 15.95 while Pieris Pharmaceuticals 20-day EMA is 16.55, which makes it a Sell.
- Pieris Pharmaceuticals 50-day exponential moving average is 16.38 while PIRS share price is 15.95, making it a Sell technically.
- PIRS stock price is 15.95 and Pieris Pharmaceuticals 200-day simple moving average is 17.51, creating a Sell signal.
Fundamental Analysis of Pieris Pharmaceuticals
Is Pieris Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Pieris Pharmaceuticals
Should I short Pieris Pharmaceuticals stock?
- PIRS Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Pieris Pharmaceuticals is a Sell
- Pieris Pharmaceuticals Relative Strength Index (RSI) is 39.38, which suggest Pieris Pharmaceuticals is oversold
- The Bollinger Bands (25) for Pieris Pharmaceuticals is (16.3 - 17.04), which suggest Pieris Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Pieris Pharmaceuticals is (11.57 - 18.63), which suggest Pieris Pharmaceuticals is a Buy
* Pieris Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.